New Anti-Mesothelioma Antibody and Biomarker Discovered
Dr. Tsuji is working on discovering specific cancer antigens for malignant mesothelioma. A new study from the Gunma University of Health and Welfare shows a new anti-mesothelioma antibody for the diagnosis and treatment of mesothelioma. The use of antibody drugs is becoming more popular in the treatment of mesothelioma. Antibody drugs are immunotherapy treatments. They recruit your body’s germ-fighting immune system to fight against mesothelioma. One the of biggest problems with mesothelioma immunotherapy is a lack of biomarkers. Mesothelioma is Difficult to Diagnose and Treat with Biomarkers Mesothelioma is a rare and aggressive cancer often caused by asbestos exposure. Malignant mesothelioma is characterized by poor prognosis and short survival. Malignant mesothelioma is considered a treatment-resistant (intractable) cancer. Clinicians and researchers…